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Abstract
Background: MRE11 is an important nuclease which functions in the end-resection step of homologous
recombination (HR) repair of DNA double-strand breaks (DSBs). As MRE11-deficient ATLD cells exhibit hyper radio-
sensitivity and impaired DSB repair, MRE11 inhibitors could possibly function as potent radio-sensitizers. Therefore,
we investigated whether a bisbenzamidine derivative, pentamidine, which can inhibit endoexonuclease activity,
might influence DSB-induced damage responses via inhibition of MRE11.
Results: We first clarified that pentamidine inhibited MRE11 nuclease activity and also reduced ATM kinase activity
in vitro. Pentamidine increased the radio-sensitivity of HeLa cells, suggesting that this compound could possibly
influence DNA damage response factors in vivo. Indeed, we found that pentamidine reduced the accumulation of
g-H2AX, NBS1 and phospho-ATM at the sites of DSBs. Furthermore, pentamidine decreased HR activity in vivo.
Pentamidine was found to inhibit the acetylation of histone H2A which could contribute both to inhibition of IR-
induced focus formation and HR repair. These results suggest that pentamidine might exert its effects by inhibiting
histone acetyltransferases. We found that pentamidine repressed the activity of Tip60 acetyltransferase which is
known to acetylate histone H2A and that knockdown of Tip60 by siRNA reduced HR activity.
Conclusion: These results indicate that inhibition of Tip60 as well as hMRE11 nuclease by pentamidine underlies
the radiosensitizing effects of this compound making it an excellent sensitizer for radiotherapy or chemotherapy.
Background
DNA double-strand breaks (DSBs) are generated by
exposure to ionizing radiation, DNA damaging agents
such as bleomycin or neocarzinostatin, or due to the
stalling or collapse of DNA replication forks. As unre-
paired DSBs induce genome instability and promote
apoptosis or tumorigenesis, cells recognize DSBs
immediately and activate cell cycle checkpoints and
DNA repair mechanisms. Hence, the generation of
DSBs by exposure to ionizing radiation (IR) could
induce cell death in tumor cells and the inhibition of
DSB repair activity in tumors might lead to efficient
radiotherapy. The generation of DSBs triggers the re-
localization of many DNA damage response (DDR)
proteins such as MRE11/NBS1/RAD50, MDC1, 53BP1
and BRCA1 to nuclear foci that co-localize with g-
H2AX [1-5]. H2AX is rapidly phosphorylated at DSB
sites and phosphorylated H2AX (g-H2AX) interacts
with NBS1, MDC1 and BRCA1, thereby promoting
their accumulation at DSBs [1,6]. Hence, H2AX-knock-
out cells are deficient in the formation of DSB-induced
nuclear foci of several DDR proteins such as NBS1
[2,6,7]. Furthermore, H2AX-knockout cells are defec-
tive in homologous recombination (HR) repair [8].
Both H2AX+/- and H2AX-/- mouse thymocytes show
an increase in chromosomal aberrations [9,10]. These
facts indicate that g-H2AX-depedent foci formation
could be important for DSB repair, particularly HR
repair, and genome stability.
MRE11 nuclease is a key factor in DSB damage
response and functions as both a single- and double-
stranded DNA endonuclease as well as 3’->5’ exonu-
clease [11,12]. It has been reported that this nuclease
activity is indispensable for homologous recombination,
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tion using yeast cell lines lacking functional Mre11
[13,14]. Mutations in the hMRE11 gene result in Ataxia
Telangiectasia-like disorder (AT-LD) syndrome. Both
AT-LD patient cells and ATM-defective Ataxia Tela-
giectasia patients cells show similar phenotypes such as
radio-resistant DNA synthesis, radiation hyper-sensitiv-
ity and genome instability [15-17]. hMRE11 forms a
complex with NBS1 and hRAD50 and this complex dis-
plays DNA binding and tethering activities as well as
nuclease activity. This complex has been shown to func-
tion in DNA double-strand break repair by HR in mam-
mals [18,19]. Moreover, efficient HR repair requires IR-
induced focus formation (recruitment) of the NBS1/
hMRE11/hRAD50 complex at DNA damage sites [20].
Hence, the genomic instability in AT-LD patients could
be due to the defect in HR. Therefore, the inhibition of
hMRE11 nuclease activity or recruitment of this com-
plex may result in radiosensitization.
The bisbenzamidine derivative, pentamidine, has been
one of the most successful agents against eukaryotic
parasites and has been used clinically against trypanoso-
miasis, leishmananiasis, and Pneumocystis carinii for
over 70 years [21-23]. Pentamidine enters parasite cells
rapidly and appear first in the kinetoplast that contains
the mitochondrial DNA of the parasite. With time it is
also generally seen in the cell nucleus but significant
amounts are not observed in the cytoplasm. Pentamidin
is capable of binding to the minor groove of double-
strand DNA but not single-strand DNA and inhibits
protein synthesis, DNA synthesis and the activity of
endo-exonuclease in Pneumocystis carinii [24]. Further,
DNA and protein synthesis in human tumor also
decreased by pentamidine treatment [25]. Recently, it
was reported that pentamidine also inhibited human
endo-exonuclease activity in vitro and induced cell
death in several tumor cells efficiently [26]. Although it
is unclear as to whether pentamidine might inhibit
other nucleases such as hMRE11, the effect of pentami-
dine on hMRE11 could potentially lead to anti-tumori-
genic effects or effective radiotherapy.
In this paper, we first demonstrate the inhibitory effect
of pentamidine to hMRE11 nuclease activity in vitro.
We also show that pentamidine increases the radio-sen-
sitivity of HeLa cells and represses IR-induced focus for-
mation of g-H2AX and NBS1. Furthermore,
pentamidine reduces the HR activity and acetylation of
h i s t o n eH 2 A ,m e d i a t e db yT i p 6 0h i s t o n ea c e t y t r a n s f e r -
ase (HAT). Moreover, pentamidine reduces the HAT
activity of Tip60 in vitro. We discuss that such these
novel inhibitory effects of pentamidine on hMRE11 and
Tip60 opens up important therapeutic and radiosensitz-
ing options for cancer therapy.
Results
Pentamidine inhibits in vitro MRE11 nuclease activity and
ATM kinase activity
It has been previously reported that some dicationic dia-
ryfurans such as pentamidine inhibit the endo-exonu-
clease in Pneumocystus carinii [24]. As human endo-
exonuclease activity was also reported to be repressed
pentamidine in vitro [26], we investigated whether pen-
tamidine was capable of inhibiting hMRE11 nuclease
activity in vitro (Fig. 1A). Digestion of the hMRE11 sub-
strate was completed by 90 mins. Importantly, upon
addition of pentamidine (2 mM) substrate digestion was
almost completely inhibited even after 90 mins. Thus,
pentamidine could inhibit hMRE11 nuclease activity in
vitro. The MRN complex is known to bind with ATM
kinase directly and this interaction is essential for the
activation of ATM [27]. Hence, we next examined
whether pentamidine could influence ATM kinase activ-
ity in vitro (Fig. 1B). Immunoprecipitated ATM from
un-irradiated cells exhibited low levels of p53 phosphor-
ylation activity and this was increased 1.73 times upon
irradiation. However, the addition of pentamidine (1 or
2 mM) resulted in an obvious decrease in ATM kinase
activity. Thus, pentamidine reduced both hMRE11
nuclease and ATM kinase activities in vitro. As these
activities are very important for IR-induced DNA
damage responses and subsequent fate of the cells, pen-
tamidine would be expected to increase radio-sensitivity.
Therefore, the effect of pentamidine treatment on radio-
sensitivity was examined in HeLa cells (Fig. 1C). The
viability after 5 Gy of irradiation is about 0.2, but the
addition of pentamidine (0.05 mM) decreased the cell
viability to approximately 0.08. Further, the treatment of
0.1 mM pentamidine also increased radio-sensitivity in
HeLa cells (Additional file 1,F i g .S 1 ) .M o r e o v e r ,0 . 0 5
mM of pentamidine treatment induced a few multinu-
cleated cells without irradiation, and irradiation
increased the number of multinucleated cells (Fig. 1D).
Multinucleation upon pentamidine treatment might be a
consequence of the cells proceeding into mitosis without
appropriate DSB repair or cell cycle checkpoint imple-
mentation resulting in mitotic catastrophe.
Pentamidine represses the formation of DNA-damage
responsive foci upon irradiation
Fig. 1 indicated that very low concentration (0.05 mM)
of pentamidine influenced the radio-sensitivity and
multi-nuclear formation in vivo, although more than 0.5
mM of pentamidine is required for inhibition to
hMRE11 activity or ATM kinase activity in vitro. As
hMRE11/ATM are some of the earliest responders to
DSBs and trigger many aspects of DDR, pentamidine
may influence the function of other factors in DNA
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proteins into “foci” following IR is early and important
event in DNA damage-induced cellular response, parti-
cularly g-H2AX foci, which are formed before most
DNA damage responses. Therefore, we investigated the
effect of pentamidine on g-H2AX focus formation fol-
lowing IR (Fig. 2AB). Without pentamidine treatment,
most cells exhibited g-H2AX focus formation after an
exposure to 5 Gy of g-ray. Pre-treatment with pentami-
dine (more than 0.5 mM) resulted in a striking reduc-
tion in focus formation. Previously, we reported that the
IR-induced focus formation of NBS1, which forms a
complex with hMRE11 and hRAD50, is dependent on g-
H2AX [1]; therefore, we verified the inhibitory effect of
pentamidine on the formation of NBS1 foci following
irradiation (Fig. 2C and Additional file 1, Fig. S2 and
S3). Similarly to g-H2AX foci, IR-induced NBS1 focus
formation was decreased by pre-treatment of pentami-
dine. Pentamidine also repressed focus formation by
hMRE11, MDC1 and phospho-ATM, whose accumula-
tion at DSBs is dependent on g-H2AX or NBS1 (Fig.
2C). Recently, Chromatin-immunoprecipitation (ChIP)
has been effectively used to clarify the recruitment
(accumulation) of DNA damage-related factors to DSB
sites [28]. Usually, the recruitment of factors that accu-
mulated as IR-induced foci, is also detectable by ChIP
Figure 1 The inhibitory effect of pentamidine on an hMRE11 nuclease and an ATM kinase. (A) Pentamidine inhibited hMRE11 nuclease.
hMRE11 nuclease assay was performed using recombinant MRN complex. Indicated amount of pentamidine is added to the reaction mixture.
(B) Pentamidine inhibited ATM kinase. Normal lymphoblastoid cells (GM2184) were irradiated by 10 Gy of g-irradiation and the kinase activity
assay was performed using immuno-complex by anti-ATM antibody or control rabbit IgG from these cells. Indicated concentration of
pentamidine is added to the reaction mixture. (C) Pentamidine treatment increased radiation sensitivity. HeLa cells were irradiated with indicated
dose of g-ray with or without pentamidine (0.05 mM) and the viability of their cells were analyzed by colony forming assays. (D) Pentamidine
treatment induced multinuclear formation. HeLa cells were irradiated with 5 Gy of g-ray with or without pentamidine (0.05 mM) and cell
morphology was observed after 24 hours.
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or NBS1 near DSB sites by ChIP assay, these recruit-
ments were detected without pentamidine treatment
(Additional file 1, Fig. S4). However, pre-treatment with
pentamidine repressed these recruitments (g-H2AX: 0
and 4 kb; NBS1: 0 kb), which is consistent with the
results of focus formation in Fig. 2ABC. However, the
accumulation of g-H2AX at 1 kb distance was not
repressed by pentamidine. As the formation of g-H2AX
is composed by two steps; ATM/NBS1-dependent pri-
mary phosphorylation and subsequent MDC1-dependent
accumulation [7]. Hence, inhibitory effect of pentami-
dine might be different between two steps. As Fig. 1B
showed that pentamidine could inhibit ATM kinase
activity and Fig. 2AB showed that pentamidine reduced
ATM-dependent g-H2AX focus formation, we investi-
gated whether pentamidine could repress ATM-depen-
dent DDR phosphorylation events (Fig. 3A). Irradiation
with g-rays (5 Gy) induced phosphorylation of SMC1,
Chk2, and p53, for which ATM is the responsible
kinase. However, 0.5 mM of pentamidine treatment did
not reduce these phosphorylation. Moreover, the treat-
ment of 1 mM of pentamidine, which can diminish
almost g-H2AX focus formation, did not influence these
phosphorylation in both MRC5SV and HeLa cells (Addi-
tional file 1, Fig. S5AB). However, 2 mM of pentamidine
Figure 2 The effect of pentamidine on IR-induced cellular response. (A) Pentamidine repressed g-H2AX foci formation. MRC5SV cells were
irradiated with 5 Gy of g-ray with or without pre-treatment of pentamidine (indicated concentrations, 30 minutes). After 30 minutes, their cells
were fixed and immuno-staining was performed using anti-g-H2AX. Percentage of g-H2AX foci-positive cell was shown in (B). (C) Pentamidine
repressed focus formation of DNA damage-related factors. MRC5SV cells were irradiated with 5 Gy of g-ray with or without pre-treatment of
pentamidine (0.5 mM, 30 minutes). After 30 minutes, their cells were fixed and immuno-staining was performed using anti-NBS1, anti-phospho-
ATM, anti-hMRE11 and anti-MDC1 antibodies.
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SMC1 phosphorylation (Additional file 1, Fig. S5C),
which is consistent with the inhibitory effect on ATM
kinase activity in vitro (Fig. 1B). Moreover, low concen-
tration of pentamidine also showed no effect on DNA-
PK or ATR-dependent phosphorylations (Fig. 3B).
Taken together, low concentration of pentamidine
might repress IR-induced foci formation and accumula-
tion of proteins such as g-H2AX independently of inhi-
bition to ATM kinase in vivo.
Pentamidine represses both homologous recombination
repair and histone acetylation
Various DNA damage-related proteins form nuclear foci
at DSB sites, and many of them, such as the MRN com-
plex, g-H2AX, BRCA1, Rad51, are known to function in
homologous recombination repair [8,20,29]. As Fig. 2
indicated that pentamidine reduced their focus forma-
tion, we next examined whether pentamidine repressed
HR repair. When we used the DR-GFP system devel-
oped by the Jasin laboratory [30] to estimate HR activity
in MRC5SV cells, the generation of DSB by an expres-
sion of I-SceI restrection enzyme induced approximate
28% of GFP-positive cells (Fig. 4A). Pre-treatment with
pentamidine reduced GFP-positive cells to 16% after I-
SceI introduction. In the case of HeLa cells, similar
effect of pentamidine was observed (Fig. 4B). We also
estimated the effect of pentamidine on NHEJ repair, but
the frequency of GFP-positive cells via NHEJ pathway
was unchanged with or without pentamidine treatment
(Fig. 4C). These results suggest that prentamidine could
repress HR repair activity. Recently, the importance of
histone modification, particularly, its acetylation in HR
repair has been reported [31]. Using the DR-GFP assay
we found that the histone acetytransferase (HAT)-speci-
fic inhibitors anacardic acid and curcumin reduced HR
activity, but Trichostatin A (histone deacetylase inhibi-
tor) did not influence the HR activity (Additional file 1,
Fig. S6), suggesting that histone acetylation is indispen-
sable for HR. Surprisingly, pentamidine reduced the
acetylation of histone H2A at Lys5 dramatically, and the
acetylation of H2A at Lys9 was also decreased, although
g-irradiation did not increase the acetylation of these
histones (Fig. 5A). As this acetylation was expected to
have an important role in DNA damage responses, we
generated exogenous FLAG-H2AX (WT or K5/9R
mutants)-expressing MRC5SV cells. K5/9R-H2A-expres-
sing cells exhibited a decrease in NBS1-focus formation
following IR (Fig. 5BC). Moreover, the HR activity in
K5/9R-H2A-expressing cells was much less than that in
WT-H2A-expressing cells (Fig. 5D). Taken together, the
acetylation of H2A at Lys5 and Lys9 appears to play an
important role in HR repair and pentamidine might
influence the IR-induced focus formation and HR repair
through a repression of histone H2A acetylation.
Pentamidine inhibits Histone acetyltransferase, Tip60
Fig. 5 indicates the possibility that pentamidine might
inhibit the acetylation of histone H2A in addition to
inhibiting the activities of hMRE11 and ATM (Fig.
1AB). Hence, the decrease in histone H2A acetylation
m i g h tb ea ni n d i r e c te f f e c to fp e n t a m i d i n et h r o u g h
ATM or hMRE11 activity. However, ATM inhibitors did
not influence the acetylation of H2A with or without
irradiation (Additional file 1, Fig. S7A), although it
reduced SMC1 phosphorylation. hMRE11-deficient
ATLD cells showed normal levels of acetylation (Addi-
tional file 1, Fig. S7B), suggesting that hMRE11 nuclease
activity is dispensable for an acetylation of histone H2A.
Figure 3 The effect of pentamidine on ATM/ATR/DNA-PK-
dependent phosphorylation. (A) Pentamidine did not disturb
ATM-dependent phosphorylation. MRC5SV cells were irradiated by 5
Gy of g-ray with or without pre-treatment of pentamidine (0.5 mM,
30 minutes). These cells were harvested at 0.5 hour after IR and
analyzed by Western blot using indicated antibodies. (B)
Pentamidine did not disturb ATR or DNA-PK-dependent
phosphorylation. MRC5SV were irradiated by 5 Gy of g-ray with or
without pre-treatment of pentamidine (0.5 mM, 1 hour). These cells
were harvested at 0.5 hour after IR and analyzed by Western blot
using indicated antibodies.
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responsible for histone acetylation and can acetylate his-
tone H2A in vitro [32]. Further, several lines of evidence
suggests that Tip60 might function in DSB damage
response [31,33]. Therefore, we examined whether the
repression of Tip60 by siRNA result in an effect that is
similar to pentamidine treatment. Tip60-knock-down
cells showed clear reduction of H2A acetylation at Lys5
and Lys9, but did not influence the acetylation of H3,
H2B, and H4 (Fig. 6A). Moreover, the repression of
Tip60 also reduced HR activity in DR-GFP system (Fig.
6B). These results suggest that Tip60 is a crucial acetyl-
transferase for histone H2A and plays a role in HR
repair through the acetylation oh histone H2A. We next
investigated if pentamidine directly inhibit Tip60 activity
in vitro (Fig. 6C). Immunoprecipitated Tip60 could acet-
ylate recombinant H2A in vitro and 10 Gy of irradiation
increased this activity. However, the addition of penta-
midine abolished the induction of Tip60 activity. Tip60
is reported to acetylate p53 at Lys120 as well as hisotone
H2A at Lys5 and Lys9 [34]. Pentamidine treatment also
reduced Tip60-dependent acetylation of p53 in
MRC5SV cells (Fig. 6D), suggesting that pentamidine
could inhibit Tip60 acetyltransferase acitivity in vivo.
Taken together, pentamidine could repress histone acet-
ylation through direct inhibition of Tip60 histone acetyl-
transferase, and this repression might leads to a decrease
in HR repair activity and cell viability after irradiation.
Figure 4 The effect of pentamidine on DNA double-strand break repair (A)(B) Pentamidine decreased homologous recombination
activity in DR-GFP assay. I-SceI expression plasmids were introduced to M5D (A) or HeLa-DRGFP cells (B) by an electroporation with or without
pre-treatment of pentamidine (0.5 mM, 1 hour). After 3 days GFP-positive cells, induced via HR pathway, were analyzed by flowcytometer as
described in Materials and Methods. (C) Pentamidine did not disturb NHEJ activity. I-SceI expression plasmids were introduced to MRC5-pEJ cells
by electroporation with or without pre-treatment of pentamidine (0.5 mM, 1 hour). After 3 days GFP-positive cells, induced through NHEJ
pathway, were analyzed by flowcytometer as described in Materials and Methods.
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We identified here that pentamidine is a novel inhibitor
of hMRE11 nuclease (Fig. 1A). Pentamidine also
repressed ATM kinase activity in vitro (Fig. 1B). Low
concentrations of pentamidine enhanced radio-sensitiv-
ity of HeLa cells (Fig. 1C), suggesting that pentamidine
might influence other factors in DNA damage response.
Pentamidine reduced IR-induced focus formation of
DDR proteins such as g-H2AX and NBS1, although a
remarkable effect on ATM-dependent phosphorylations
was not observed (Fig. 2 and 3). Pentamidine also
repressed HR activity but not NHEJ (Fig 4). Furthemore,
pentamidine reduced acetylation of histone H2A (Fig.
5A), which is suggested to influence IR-induced focus
formation and HR repair. H2A mutated at acetylation
sites decreased both IR-induced focus formation of
NBS1 and HR activity (Fig. 5BCD). Knockdown of
Tip60, which is known as a histone acetyl transferase,
resulted in effects on H2A acetylation and HR activity
similarly to that seen upon pentamidine treatment (Fig.
6AB). Moreover, pentamidine reduced HAT activity of
Tip60 in vitro and Tip60-dependent acetylation of p53
in vivo (Fig. 6CD), suggesting that the inhibitory effects
of pentamidine on DDR may be mediated, at least in
part, by inhibitin of Tip60. However, the effects of
Tip60-knockdown were less pronounced than those by
pentamidine treatment (Fig. 6B). Taken together, penta-
midine might influence IR-induced DNA damage
response through the inhibitory effect on not only
Tip60, but also hMRE11 and ATM.
Pentamidine is known to be as one of the most effec-
tive agents against Pneumocystis carinii. Pentamidin is
capable of binding to the minor groove of double-strand
DNA and inhibits protein synthesis, DNA synthesis and
the activity of endo-exonuclease in Pneumocystis carinii
[24]. Pentamidine also repressed Saccharomyces cerevi-
siae RNC1/TRM2 endo-exonuclease, which displayed 5’-
>3’ exonuclease activity on double-strand DNA and
endonuclease activity on single-strand DNA in vitro
[35]. Recently, it was reported that pentamidine also
Figure 5 Pentamidine might affect DNA damage response through acetylation of histone H2A. (A) The effect of pentamidine on histone
acetylation. MRC5SV cells were irradiated with 5 Gy of g-ray with or without pre-treatment of pentamidine (0.5 mM, 30 minutes). These cells
were harvested at indicated times after IR and analyzed by Western blot using indicated antibodies. (B) Acetylation of histone H2A is required for
IR-induced foci formation. H2A-WT or H2A-K5/9R-expressing cells were generated as described in Materials and Methods. These cells were
irradiated with 5 Gy of g-ray. After 30 minutes, their cells were fixed and immuno-staining was performed using anti-NBS1 and anti-FLAG
antibodies. Percentage of NBS1 foci-positive cells was shown in (C). (D) HR activity in H2A (K5/9R)-expressing cells. I-SceI expression plasmids
were introduced into H2A-WT or H2A-K5/9R- expressing cells by electroporation. After 2 days GFP-positive cells, induced through HR pathway,
were analyzed by flowcytometer.
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These observations suggest that pentamidine might
show an inhibitory effect on other nuclease such as
hMRE11 in mammalian cells. Indeed, our results
demonstrate that addition of 2 mM pentamidine abol-
ished hMRE11 nucelase activity in vitro (Fig. 1A), sug-
gesting that pentamidine could be used as an effective
inhibitor in human cells. We also showed that pentami-
dine reduced ATM kinase acitivity. As ATM requires
MRN complex for optimal activation [27], the effect of
pentamidine on ATM kinase activity might occur via
repression of hMRE11 nuclease by pentamidine. Future
experiments will be aimed at clarifying whether penta-
midine reduces ATM kinase activity directly.
Recently, several reports suggest a tight relationship
between histone acetylation and DNA damage response.
Tamburini and Tyler showed that acetylation of histone
H3 and H4 increased at HO endonuclease-restricted
DSB sites in yeasts by ChIP assay and also showed that
the histone acetyltransferases Gcn5 and Esa1 were
recruited at these DSB sites [36]. Downs and his collea-
gues also reported that Arp4, a subunit of NuA4 HAT
complex interacts with phosphorylated H2A directly and
Arp4 was recruited to HO-related DSB sites [37].
Further, human homologous of NuA4 HAT, Tip60
interact with hitstone H2AX and could acetylated it,
and also showed that acetylation of histone H2AX
increased in response to DSB damage [33]. Furthermore,
the strains of S. pombe or S. cerevisieae expressing
mutated H3 or H4 at acetylation sites or HAT-deficient
yeasts increased the sensitivity to DNA damaging agents
in yeast and dominant-negative Tip60-expressing HeLa
cells showed the delay of DSB repair following IR by
comet assay [32,36]. These reports suggest that acetyla-
tion of histon is important for DNA damage response
and, perhaps, DNA repair. This is consistent with our
results showing that the H2A-K5/9R (acetylation site
mutant)-expressing cells showed a decrease in HR repair
activity (Fig. 5D) and Tip60-knockdown cells also
reduced the HR activity (Fig. 6B). We also indicated that
pentamidine treatment and the H2A (K5/9R)-expressing
cells repressed both focus formation and HR (Figs
2ABC, 4AB and 5BCD), suggesting that focus formation
of DNA damage-related factors such as NBS1 and g-
H2AX contributes to HR repair pathway through his-
tone acetylation. In fact, a partner protein of Tip60,
TRAPP-knockout mouse cells showed a decrease in
accumulation of histone acetylation at DSB sites, IR-
induced focus formation such as BRCA1 or Rad51 and
HR activity [31]. Moreover, we reported that the defect
of MRE11 focus formation in mutated NBS1-expressing
cells leads to reduction of HR activity [20]. Thus, focus
formation of DNA damage response factors could be
closely related with homologous recombination repair.
Figure 6 Tip60-knockdown also repressed both HR activity and acetylation of histone H2A. (A) Tip60-knockdown reduced acetylation of
histone H2A. MRC5SV cells were transfected by Tip60 siRNA. After 2 days, these cells were irradiated by 5 Gy of g-ray and were harvested at
indicated times after IR and analyzed by Western blot using indicated antibodies. (B) HR activity in Tip60-knockdowned cells. M5D cells were
transfected by Tip60 siRNA. After 2 days, I-SceI expression plasmids were introduced by electroporation. After 3 days, GFP-positive cells were
analyzed by flowcytometer. (C) The effect of pentamidine on HAT activity of Tip60. Whole cell extract was prepared from irradiated or un-
irradiated HeLa cells. And then, Tip60-dependent HAT activity was measured with or without pentamidine (5 μM) as described in Material and
Methods. (D) Pentamidine repressed Tip60-dependent acetylation of p53. MRC5SV cells were added by 0.5 mM adriamycin with or without pre-
treatment of pentamidine (0.5 mM, 30 minutes). These cells were harvested after 4 hours and analyzed by Western blot using anti-acetylated
p53 antibody.
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through repression of histone acetylation, related with
IR-induced focus formation.
So far, it was reported that the bisbenzamidine deriva-
tive, pentamidine showed the growth repression against
s e v e r a lt u m o rc e l l ss u c ha sM C F 7a n dH e L ac e l l sv i a
repression of endo-exonuclease activity [26]. The paper
also showed that normal human diploid fibroblats are
not sensitive to pentamidine and pentamidine displayed
an inhibitory effect on tumor growth in mouse model.
These facts suggest that pentamidine might be an effec-
tive anti-tumor reagent. Moreover, pentamidine has a
synergistic inhibitory effect to tumor growth with mito-
mycin C or other anti-growth reagent, suggesting that
pentamidine may show a synergistic action with ionizing
r a d i a t i o n[ 3 8 , 3 9 ] .I nf a c t ,F i g .1 Cs h o w st h ee x p e c t e d
effect with irradiation of g-ray, and hence lower concen-
tration (0.05 mM) of pentamidine might be an effective
sensitizer for radiotherapy. However, much higher con-
centration of pentamidine was required for inhibitory
effects on Mre11 nuclease and ATM kinase activity in
vitro (Fig. 1AB), while middle range concentration of
pentamidine reduced Tip60 activity in vitro and in vivo
(Fig. 6CD). These results suggest that the effect of pen-
tamidine (low concentration) as a radiation sensitizer
could be due to an inhibitory effect on Tip60. In order
to use pentamidine or other deamidine analogues with
radiotherapy or chemotherapy, we need to clarify all the
targets of these reagents in DNA damage response and
the underlying mechanisms in detail.
Conclusion
In conclusion we have found the inhibitory effect of
pentamidine on Tip60 acetyltransferase and ATM
kinase. This effect caused a repression of DDR factors’
focus formation and an enhancement of radio-sensitivity
particularly via a reduction of histone H2A acetylation.
We also found that both the acetylation of histone H2A
and the role Tip60 are important for IR-induced focus
formation and homologous recombination repair.
Therefore, the further research of pentamidine could
find an excellent sensitizer for radiotherapy or
chemotherapy.
Materials and methods
Pentamidine
Pentamidine (pentamidine isethionate; Chugai Co.,
Japan) is dissolved in sterile water and stored at 4°C.
Cell lines
MRC5SV cells were SV40-transformed MRC5 human
fibroblasts [7,40]. NBS fibroblast cell line,
GM07166VA7, was established by SV40-transformation
of GM07166 cells, which were provided from NIGMS
Cell Repository [40]. AT-LD fibroblast cell line,
ATLD2SV was established by SV40-transformation of
ATLD2 primary fibroblasts, which were supplied by Dr
Y. Shiloh [41]. Normal lymphoblastoid cell line,
GM2184 was also obtained from NIGMS Cell Reposi-
tory. H2A (WT) or H2A (K5/9R)-expressing M5D cells
were generated by a transfection of pCMV-Tag2 plas-
mid (Stratagene) inserted with human H2A cDNA.
After G418 selection, their expression in isolated cells
were confirmed by Western blot analysis.
Antibodies
Phospho-ATM (S1981) rabbit polyclonal antibody
(Epitomics Inc.), phospho-SMC1 (S966) rabbit poly-
clonal and SMC1 rabbit polyclonal, MDC1 rabbit
polyclonal antibodies (Bethyl Laboratories Inc.), phos-
pho-p53 (S15) mouse monoclonal, phospho-Chk2
(T68) rabbit polyclonal antibodies (Cell Signaling
Technology), hMre11 rabbit polyclonal and Nbs1 rab-
bit polyclonal antibodies (Novus Biologicals), and
Chk2 rabbit polyclonal and anti Tip60 rabbit polyclo-
nal antibodies (Santa Cruz Biotechnology), and g-
H2AX mouse monoclonal acetyl H2A (K5) rabbit
polyclonal, acetyl H2A (K9) rabbit polyclonal, acetyl
H2B rabbit polyclonal, acetyl H3 rabbit polyclonal,
acetyl H4 rabbit polyclonal, histone H2A rabbit poly-
clonal and histone H4 rabbit polyclonal antibodies
(Millipore Co.), and p53-acetyl-K120 mouse monoclo-
nal (BioAcademia) were used for Western blot analysis
or immuno-staining.
SiRNA knock-down experiments
Sub-confluent cells, seeded to culture dishes the day
before, were transfected by Tip 60 (Be-Bridge Interna-
tional Inc.) or negative (Be-Bridge International Inc.)
siRNA using lipofectamine 2000 (Invitrogen Life Tech-
nology). After 2 days, these cells were re-seeded in
proper culture dishes. Next day, these cells were used
for Western blot or DR-GFP analysis.
Western Blot analysis
Western blot analysis was carried out as described pre-
viously [1]. Target proteins were detected with primary
antibodies, mentioned above, and HRP-conjugated anti-
rabbit IgG or anti-mouse IgG antibodies (GE Helthcare),
and then visualized with an ECL plus chemilumines-
cence system (GE Helthcare).
Immunofluorescent staining
Immunofluorescent staining was carried out as
described previously [1]. Alexa-488-conjugated anti-rab-
bit IgG (Molecular Probes) or Alexa-594-conjugated
anti-mouse IgG (Molecular Probes) were used for visua-
lization of foci of target protein.
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ATM kinase assay was carried out as described pre-
viously [7]. ATM was immunoprecipitated with an anti-
ATM antibody (Calbiochem). Phosphorylation of p53
(substrate) by immunoprecipitated ATM in vitro in the
presence of [g-
32P]-ATP was detected by BAS2000 (FUJI
Film Co.).
MRE11 nuclease assay
MRE11 nuclease assay was performed as previously
reported [11,12]. MRN complex proteins for this assay
are purified as previously reported [12]. MRE11 nuclease
reactions (containing 25 mM MOPS [pH 7.0], 50 mM
NaCl, 2 mM DTT, 1 mM MnCl2,0 . 1p m o l eo fD N A
substrate labeled by [g-
32P]-ATP and 150 ng of MRN
complexes), were performed in a volume of 10 μl, and
were incubated at 37°C for 30 min. Reactions were
stopped by the addition of EDTA and SDS to final con-
centrations of 10 mM and 0.2%, respectively. Each reac-
tion was dried down, resuspended in 5 μl of formamide
loading buffer, and then loaded onto a sequencing gel
containing 15%-22.5% acrylamide and 7 M. After the
run, each gel was analyzed with BASS2000.
Cell survival assay
For radiation sensitivity assays, the cells were trypsinized
a n di r r a d i a t e dw i t h1 ,3 ,o r5G yo f
60Co g-ray at a dose
rate of 1.1 Gy/min. Immediately after irradiation, cells
were plated into 100-mm dishes at such a cell density
that 30-40 cells would survive, and incubated for 14
days. The dishes were fixed with ethanol, stained with
4% Giemsa, and the number of colonies were counted.
Surviving fractions were calculated by comparing the
number of colonies formed by irradiated cells with the
number of colonies formed by non-irradiated control
cells. Each result represents an average value from 3
experiments.
Homologous Recombination assay (DR-GFP) assay
DR-GFP was performed as previously reported [20,30].
To measure the repair of an I-SceI-generated DSBs, 50
μg of the I-SceI expression vector (pCBASce) was intro-
duced to 1000000 M5D cells, by electroporation (Gene-
Pulser; BIO-RAD). To determine the amount of HR
repair, the percentage of cells, that were GFP-positive,
was quantified by flow cytometry 3 days after electro-
poration with FACScalibur (Becton Dickinson).
NHEJ assay
NHEJ was performed as previously reported [42]. To
measure the repair of an I-SceI-generated DSBs via
NHEJ pathway, 50 mg of the I-SceI expression vector
pCBASce was introduced to 1000000 MRC5SV-pEJ
cells, by electroporation (BIO-RAD). To determine the
amount of NHEJ repair, the percentage of GFP-positive
cells was quantitated with flow cytometric analysis at 3
days after electroporation by FACScalibur (Becton
Dickinson).
In vitro histone acetylation assay by Tip60
DNA damage-treated or untreated cells were lysed in IP
buffer (150 mM sodium chloride, 10 mM Tris/HCl
[pH7.4] and 0.5% NP40) containing a protease inhibitor
cocktail (Roch) and sodium orthovanadate for 15 min.
Lysates were centrifuged at 20,000 × g for 30 min to
remove un-solubulized debris. Lysates were pre-cleared
with protein A-Sepharose beads (GE healthcare), and
immunoprecipitation was performed by incubating the
samples with anti-Tip60 antibody (Santa Cruz) at 4°C
for 1 hour. After washing by IP buffer, these immuno-
precipitants were used for in vitro histone acetylation
assay. Reaction of Tip60-dependent histone acetylation
(50 mM Tris/HCl [pH 8.0], 10% grycerol, 0.1 mM
EDTA, 1 mM DTT, 1 mM PMSF, 10 mM sodium Buty-
r a t e ,2 0m MA c e t y lC o A ,1 0μgo fh i s t o n eH 2 A )w a s
performed at 37°C for 30 minutes and the reaction was
stopped by addition of SDS-PAGE loading buffer. The
actylated histone H2A in the reaction was detected by
Western blot analysis using anti-acetyl H2A (K9) rabbit
polyclonal antibody.
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